{"schema_version":"secwatch.filing_event.v1","accession":"0001903596-23-000077","form_type":"8-K","ticker":"KAYS","cik":"0001530746","company_name":"Kaya Holdings, Inc.","filed_at":"2023-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.412378+00:00","generated_at":"2026-06-20T06:35:54.592168+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kaya Holdings launches Fifth Dimension Therapeutics to enter psychedelic treatment market","bullets":["Fifth Dimension Therapeutics will target PTSD, addiction, eating disorders, and treatment-resistant mental health conditions.","Employee Bryan Arnold enrolled in Oregon Psilocybin Facilitator training; expected to complete and apply for license in April 2023.","Attorney Glenn E.J. Murphy joins FDT board to assist with pharma partnerships, IP, and funding opportunities.","Company cites $2.8B U.S. psychedelics market in 2021, forecast to reach $8.9B by 2029.","KAYS shifts cannabis focus to Europe while launching psychedelic 'mind care' operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001903596-23-000077","json":"https://secwatch.observer/filing/0001903596-23-000077.json","markdown":"https://secwatch.observer/filing/0001903596-23-000077.md","text":"https://secwatch.observer/filing/0001903596-23-000077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530746/000190359623000077/0001903596-23-000077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530746/000190359623000077/f2skays8k012723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T06:35:54.592168+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}